T1	Participants 42 72	infants with atopic dermatitis
T2	Participants 130 217	ETAC (Early Treatment of the Atopic Child), a multi-centre predominantly European study
T3	Participants 302 332	infants with atopic dermatitis
T4	Participants 359 501	817 children have been randomised to 18 months' treatment with either active or placebo and a subsequent 18 months of post-treatment follow-up
T5	Participants 678 814	large cohort of 1-2 years olds with already established atopic dermatitis, resident in different countries and in different environments
